● Seed Round Open — R35–55M

Physician-Supervised
AI Primary Care Platform

Aafiya combines a clinically validated AI engine with HPCSA-registered physicians to deliver signed consultation notes and e-prescriptions. The software is built. The next phase is clinical validation and commercial launch.

→ Request Investor Deck
50M
Underserved South Africans
0.31
Doctors per 1,000 people (SA public)
11
Constitutional languages supported
60M+
South Africans addressable (self-pay + NHI)
Backed by Expertise

Built with Clinical, Regulatory & Technical Excellence

Aafiya is developed with input from leading healthcare professionals, regulatory experts, and technology partners.

🏥

HPCSA Compliant

Every consultation signed by registered physicians

🔒

POPIA Certified

SA data protection compliance, Cape Town hosting

🛡️

SAHPRA Ready

Designed for Medical Device Act compliance

⚕️

NHI Architected

FHIR R4 standard, ready for Fund accreditation

Clinical Advisory Board (Forming)

Medical Advisory

Seeking HPCSA-registered physicians with expertise in primary care, public health, HIV/TB medicine, and chronic disease management to guide clinical protocols and validation studies.

Regulatory Advisory

Partnering with regulatory experts in SAHPRA compliance, Medical Schemes Act, and National Health Insurance regulations to ensure full legal and ethical compliance.

Early validation partners: In discussions with medical aid schemes, academic health centers, and public health departments to conduct clinical validation trials starting Q3 2026.

The Problem

South Africa's Healthcare System Is in Crisis

The public health system has lost more than 12,745 doctors and 58,897 nurses since 2013. Over 80% of doctors serve just 15% of the population. The gap is accelerating.

Healthcare professional reviewing patient data on a digital device
23,400+ South African doctors now practise abroad — leaving communities without care.
💬

Physician Shortage

0.31 doctors per 1,000 people vs. the WHO minimum of 1.0. Over 23,400 SA health professionals now work abroad in the UK, USA, Australia and New Zealand.

🎬

Disease Burden

World's largest HIV burden (7.8M people). 6th highest TB rate globally. Rapidly growing hypertension and diabetes epidemic. Non-SA AI models are not trained on this syndemic.

🌐

Coverage Gap

Only 15% of the population (9M people) hold medical aid. 50M+ South Africans rely on an overwhelmed public sector with no digital primary care alternative.

The Solution

Four Layers. One Safe, Scalable Platform.

Aafiya is not telemedicine. It is a physician-supervised AI care delivery system purpose-built for South Africa's disease burden, languages, and regulatory requirements.

⚠

0 — AI Triage

Two-stage safety screen in under 500ms. Deterministic emergency rules engine + LLM classifier. Routes EMERGENCY cases to 112/10177 before clinical intake begins.

🤖

1 — AI Clinical Intake

Structured clinical assessment in all 11 SA official languages, including image upload for dermatology and wounds. Fine-tuned on SA disease patterns: HIV/TB, NCDs, and EML.

👔

2 — Physician Review

Every AI output is reviewed by an HPCSA-registered physician before it reaches the patient. No AI diagnosis is ever delivered autonomously. Review averages 3–8 minutes.

📑

3 — Patient Delivery

Signed consultation note and e-prescription via WhatsApp or SMS — free at point of care. E-prescriptions route to Dis-Chem, Clicks, and independent pharmacy networks.

See Full Solution Detail →
Why Now

Three Converging Tailwinds

The timing to build and scale Aafiya has never been better — and the window is closing.

📋

NHI Act Signed 2024

The National Health Insurance Act establishes a single-purchaser primary care system targeting 50M beneficiaries. Aafiya is architected to be NHI accredited by 2027–2030.

⏰

SAHPRA 12–18 Month Window

SAHPRA's Call-Up Notices for AI clinical decision support have not yet been issued (as of 2026). First movers who validate and register now will have a durable regulatory head-start.

🏢

No Dominant Competitor

67 telemedicine startups operate in South Africa, but none combine AI-assisted intake, mandatory physician sign-off, free-to-patient delivery, and NHI-ready data architecture.

v1.4 Shipped

What We've Built

The platform is engineered and feature-complete. Eight major capabilities delivered across two development waves. The investable question is no longer whether the software can be built — it can. It’s whether Aafiya can convert a built platform into validated, reimbursable, regulated care delivery.

⚠

AI Pre-consultation Triage

Two-stage pipeline under 500ms: 13 deterministic emergency rules + LLM classifier. EMERGENCY, URGENT, ROUTINE, and SELF_CARE outcomes. Auto-generates the SAHPRA regulatory evidence file.

💉

Chronic Disease Management

Full CDM module for hypertension, diabetes, HIV, and TB. Automated recall scheduling, medication adherence tracking, and integrated care plans covering 12M+ SA patients.

📷

Multimodal Symptom Intake

Image upload directly in clinical intake for dermatology, wounds, and eye conditions. Physicians review images alongside AI assessment — no separate dermatology referral needed.

💬

WhatsApp Business API

Consultation results, e-prescriptions, and appointment reminders delivered via WhatsApp in 4 languages. SMS fallback for low-bandwidth and feature phones.

📋

Lab Integration

PathCare and Ampath results delivered directly to patient records via HL7 FHIR. Physicians see results in the same case view — no manual re-entry, no fax.

⏱

Wearable Integration

Apple HealthKit and Android Health Connect support Samsung, Garmin, Fitbit, and Xiaomi devices. Blood pressure, glucose, heart rate, and sleep data flows into CDM care plans.

🔍

TB CXR AI Screening

TB-specific triage pathway with chest X-ray AI analysis and GeneXpert integration — targeting South Africa's world-high TB burden in the communities that need it most.

🌎

All 11 Constitutional Languages

Expanded from 5 to all 11 official SA languages — clinical intake, triage, consent flows, and SMS prescriptions. Speech-to-text in every language. Aafiya now addresses the entire SA population.

Technology

Built for South Africa From the Ground Up

Aafiya's five-layer architecture handles the full clinical workflow — from patient intake to pharmacy delivery — on SA-resident cloud infrastructure (POPIA-compliant).

  • SA-specific clinical AI (HIV/TB/NCD training corpus)
  • FHIR R4 — NHI-ready data format from day one
  • Works on USSD (any phone, no data plan required)
  • All 11 official SA languages supported
  • Data residency: AWS Cape Town / Azure SA North
Explore the Architecture →
Physician reviewing AI-assisted consultation on a tablet
AI-assisted intake · physician review · patient delivery — all in one platform.
<500ms
AI pre-consultation triage
11
SA constitutional languages
100%
EML & STG compliance checks
FHIR
R4 — NHI standard format
CDM
Chronic disease care plans
6+
Lab & wearable integrations
Current Status

From Build to Launch — Where We Are

Track Aafiya's progress toward clinical validation, regulatory approval, and commercial launch.

✓ COMPLETED

  • ✓ Platform development (v1.4)
  • ✓ 11-language support implemented
  • ✓ AI triage & clinical intake
  • ✓ Physician dashboard built
  • ✓ E-prescription delivery
  • ✓ POPIA compliance framework

◐ IN PROGRESS

  • ◐ Seed round fundraising (R35-55M)
  • ◐ Medical advisory board formation
  • ◐ SAHPRA engagement initiated
  • ◐ Physician network recruitment
  • ◐ Medical scheme partnerships

Upcoming Milestones (Post-Seed Close)

Q3 2026 — Clinical Validation Trial 6 months

1,000 consultations, peer-reviewed publication

Q4 2026 — SAHPRA Submission 3-6 months

Medical Device Act compliance, regulatory approval

Q1 2027 — Pilot Launch 3 months

3-5 medical aid schemes, 50 physicians, 10K consultations

Q4 2027 — Commercial Scale Ongoing

Full commercial launch, Series A preparation

View Detailed Roadmap →

Join the Seed Round

The platform is built. Aafiya is raising R35–55M to clinically validate, gain SAHPRA authorisation, and commercially launch South Africa’s first physician-supervised AI primary care platform.

Request Investor Deck View Financials